Role of Systemic Therapy in the Management of Plaque Psoriasis

EP: 1.Understanding Plaque Psoriasis: Navigating Impact on Patients with Moderate and Mild Disease

EP: 2.Navigating Location Specific Treatment Selection and Topical Therapy Limitations

EP: 3.Consider PDE4 Inhibitors for Mild to Moderate Psoriasis

Now Viewing

EP: 4.Role of Systemic Therapy in the Management of Plaque Psoriasis

EP: 5.Exploring PDE4 Inhibitors in the Management of Plaque Psoriasis

EP: 6.Fostering Patient Wellness: Prioritizing Safety and Education in PDE4 Utilization

EP: 7.Looking Ahead: A Conversation Surrounding Closing the Gaps in Plaque Psoriasis Management

This is a video synopsis/summary of a panel discussion involving Lisa Swanson, MD, FAAD, and Robert J. Casquejo, PA-C.

In this conversation between 2 dermatologists, they discuss the misconception that psoriasis doesn't cause itching, contrary to the historical belief that only eczema does. They acknowledge that approximately 50% of their psoriasis patients experience intense itching, highlighting the significant impact on quality of life. Despite the misconception that itch severity correlates with disease severity, patients may suffer regardless of the extent of their psoriasis.

The dialogue then transitions to a more positive outlook, emphasizing the current abundance of treatment options for psoriasis. The dermatologists attribute this progress to an improved understanding of psoriasis as an inflammatory, systemic disease, allowing for the development of targeted therapies.

The conversation delves into the decision-making process for initiating systemic therapy. They share insights into their approach, considering factors such as disease severity, patient preferences, and medical history. The dermatologists emphasize the need for early intervention, aligning with recommendations from the National Psoriasis Foundation to achieve clear or almost clear skin.

The evolution of psoriasis treatment is discussed, from historical methods like tar application to the contemporary array of medications, including pills, shots, and creams. They highlight the positive impact of systemic therapies on patients' overall health, addressing comorbidities associated with psoriasis.

The dermatologists stress the importance of individualized patient care, engaging in comprehensive discussions about available treatments. Shared decision-making is encouraged, with the dermatologists guiding patients through the selection process based on factors such as medical history, preferences, and the specific profiles of available medications. They conclude by expressing gratitude for the current era of psoriasis treatment, marked by effective and safe therapeutic options.

Video synopsis is AI-generated and reviewed by DermatologyTimes editorial staff.